The Epstein-Barr Virus Lytic Protein BZLF1 as a Candidate Target Antigen for Vaccine Development.
about
The Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a Reassessment.Historical observations contributing insights on etiopathogenesis of rheumatoid arthritis and role of rheumatoid factor.A study of Epstein-Barr virus infection in the Chinese tree shrew(Tupaia belangeri chinensis).
P2860
The Epstein-Barr Virus Lytic Protein BZLF1 as a Candidate Target Antigen for Vaccine Development.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The Epstein-Barr Virus Lytic P ...... tigen for Vaccine Development.
@ast
The Epstein-Barr Virus Lytic P ...... tigen for Vaccine Development.
@en
type
label
The Epstein-Barr Virus Lytic P ...... tigen for Vaccine Development.
@ast
The Epstein-Barr Virus Lytic P ...... tigen for Vaccine Development.
@en
prefLabel
The Epstein-Barr Virus Lytic P ...... tigen for Vaccine Development.
@ast
The Epstein-Barr Virus Lytic P ...... tigen for Vaccine Development.
@en
P2093
P2860
P1476
The Epstein-Barr Virus Lytic P ...... tigen for Vaccine Development.
@en
P2093
Alex S Hartlage
Gerard Lozanski
John T Patton
Mark E Lustberg
Michael A Caligiuri
Robert A Baiocchi
Sabrina L Garman
Xiaoli Zhang
P2860
P304
P356
10.1158/2326-6066.CIR-14-0242
P50
P577
2015-03-03T00:00:00Z